Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVRx, Inc. - Common Stock (NQ: CVRX )

15.09 +0.60 (+4.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 290,436
Open 14.62
Bid (Size) 13.69 (1)
Ask (Size) 15.25 (7)
Prev. Close 14.49
Today's Range 14.56 - 15.41
52wk Range 6.400 - 23.52
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
New real-world evidence presented at THT 2025 and published simultaneously in the Journal of Cardiac Failure (JCF) demonstrates large and statistically significant reductions in hospital visits and... 
From CVRx, Inc.
Via GlobeNewswire
Skechers Posts Downbeat Results, Joins e.l.f. Beauty, LiveRamp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
+11.12%
+11.12%
1 Month
-12.77%
-12.77%
3 Month
+10.71%
+10.71%
6 Month
+77.74%
+77.74%
1 Year
-33.76%
-33.76%

More News

Read More
Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What 4 Analyst Ratings Have To Say About CVRx
Via Benzinga
Where CVRx Stands With Analysts
Via Benzinga
CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
From CVRx, Inc.
Via GlobeNewswire
Evaluating CVRx: Insights From 6 Financial Analysts
Via Benzinga
Broadcom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Insights into CVRx's Upcoming Earnings
Via Benzinga
Analyst Ratings For CVRx
Via Benzinga
CVRx Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
What Analysts Are Saying About CVRx Stock
Via Benzinga
Earnings Scheduled For February 4, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx, Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Navigating 6 Analyst Ratings For CVRx
Via Benzinga
CVRx, Inc. (CVRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
CVRX Investors Have Opportunity to Join CVRx, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
CVRX Stock Earnings: CVRx Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.